ADMA vs ORCL · P/E 22, rev $238.9M vs P/E 31, rev $67.36B
ADMA Biologics Inc (ADMA) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the ADMA and ORCL stock pages for the full models.
Not investment advice.